Literature DB >> 23877621

Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices.

Robby Nieuwlaat1, John W Eikelboom, Sam Schulman, Harriette G C van Spall, Karleen M Schulze, Benjamin J Connolly, Spencer M Cuddy, Lowiek M Hubers, Alexander C Stehouwer, Stuart J Connolly.   

Abstract

Many patients using warfarin are being managed in primary care and typically achieve a lower time in therapeutic range (TTR) for the international normalized ratio (INR) than patients in specialized care. A simple warfarin maintenance dosing tool could assist primary care physicians with improving TTR. We tested whether a simple warfarin maintenance dosing algorithm can improve TTR compared with usual care among Canadian primary care physicians. Primary care practices managing warfarin therapy without an anticoagulation clinic, computer decision support system or patient self-management tools enrolled 10-30 patients with target INR range 2-3. Practices were randomized to manage warfarin maintenance with the algorithm, or as usual in 2009-2010. Primary outcome was the mean individual patient TTR, and was compared between groups with adjustment for clustering within practices. There were 13 practices randomized to the Algorithm and 15 practices to Control, enrolling 240 and 297 patients respectively, with a mean follow-up of 280 days. Mean (standard deviation; SD) TTR before the study was comparable between groups [68 % (SD 26) for usual care vs. 70 % (SD 27) for the algorithm; p = 0.49]. Dosing decisions during the study in the algorithm group were more often in agreement with the algorithm's recommendations than with usual care (81 vs. 91 %; p < 0.0001). Mean study TTR of the algorithm group was not superior to usual care: [72.1 (SE 1.7) vs. 71.4 % (SE 1.5) respectively; p = 0.73]. The simple warfarin maintenance dosing algorithm did not improve TTR compared with usual care among Canadian primary care practices.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23877621     DOI: 10.1007/s11239-013-0969-x

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  11 in total

1.  Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy.

Authors:  Robby Nieuwlaat; Lowiek M Hubers; Alex C Spyropoulos; John W Eikelboom; Benjamin J Connolly; Harriette G C Van Spall; Karleen M Schulze; Spencer M Cuddy; Alexander C Stehouwer; Sam Schulman; Stuart J Connolly
Journal:  Thromb Haemost       Date:  2012-09-26       Impact factor: 5.249

2.  Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study.

Authors:  Y-K Kim; R Nieuwlaat; S J Connolly; S Schulman; K Meijer; N Raju; S Kaatz; J W Eikelboom
Journal:  J Thromb Haemost       Date:  2009-10-14       Impact factor: 5.824

Review 3.  Effect of study setting on anticoagulation control: a systematic review and metaregression.

Authors:  Carl van Walraven; Alison Jennings; Natalie Oake; Dean Fergusson; Alan J Forster
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

4.  Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.

Authors:  Harriette G C Van Spall; Lars Wallentin; Salim Yusuf; John W Eikelboom; Robby Nieuwlaat; Sean Yang; Conrad Kabali; Paul A Reilly; Michael D Ezekowitz; Stuart J Connolly
Journal:  Circulation       Date:  2012-10-01       Impact factor: 29.690

5.  Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.

Authors:  Sam Schulman; Sameer Parpia; Clare Stewart; Lisa Rudd-Scott; Jim A Julian; Mark Levine
Journal:  Ann Intern Med       Date:  2011-11-15       Impact factor: 25.391

6.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

7.  Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.

Authors:  Elaine M Hylek; Alan S Go; Yuchiao Chang; Nancy G Jensvold; Lori E Henault; Joe V Selby; Daniel E Singer
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

8.  A method to determine the optimal intensity of oral anticoagulant therapy.

Authors:  F R Rosendaal; S C Cannegieter; F J van der Meer; E Briët
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249

Review 9.  Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.

Authors:  Yi Wan; Carl Heneghan; Rafael Perera; Nia Roberts; Jennifer Hollowell; Paul Glasziou; Clare Bankhead; Yongyong Xu
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2008-11-05

Review 10.  Computerized clinical decision support systems for therapeutic drug monitoring and dosing: a decision-maker-researcher partnership systematic review.

Authors:  Robby Nieuwlaat; Stuart J Connolly; Jean A Mackay; Lorraine Weise-Kelly; Tamara Navarro; Nancy L Wilczynski; R Brian Haynes
Journal:  Implement Sci       Date:  2011-08-03       Impact factor: 7.327

View more
  4 in total

1.  Do specialty anticoagulation clinics really outperform primary care at INR management?

Authors:  Scott R Garrison; G Michael Allan
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

2.  Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohort.

Authors:  Sharon Liu; Alexander Singer; Finlay A McAlister; William Peeler; Balraj S Heran; Neil Drummond; Donna P Manca; G Michael Allan; Christina Korownyk; Michael R Kolber; Michelle Greiver; Scott R Garrison
Journal:  Can Fam Physician       Date:  2019-06       Impact factor: 3.275

3.  The Effect of Warfarin Administration Time on Anticoagulation Stability (INRange): A Pragmatic Randomized Controlled Trial.

Authors:  Scott R Garrison; Lee Green; Michael R Kolber; Christina S Korownyk; Nicole M Olivier; Balraj S Heran; Mary E Flesher; G Michael Allan
Journal:  Ann Fam Med       Date:  2020-01       Impact factor: 5.166

4.  Anticoagulation Management of Atrial Fibrillation: The Relationship of Prevailing Adherence to a Dose Protocol and Recall Schedule on TTR in Primary Care.

Authors:  Yogarabindranath Swarna Nantha
Journal:  Health Serv Res Manag Epidemiol       Date:  2014-09-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.